Advertisement
AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


AJPH First Look, published online ahead of print Dec 23, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2008.138115v1
99/3/452    most recent
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McDaniel, P. A.
Right arrow Articles by Malone, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McDaniel, P. A.
Right arrow Articles by Malone, R. E.
©
American Journal of Public Health, 10.2105/AJPH.2008.138115


Research and Practice

The Role of Corporate Credibility in Legitimizing Disease Promotion

Patricia A. McDaniel 1* Ruth E. Malone 1

1 University of California, San Francisco

* To whom correspondence should be addressed. E-mail: patricia.mcdaniel{at}ucsf.edu.


   Abstract

Objectives. We explored what corporate ‘‘credibility’’ means to tobacco companies to determine why it matters to companies and what a lack of credibility means to them.

Methods. We collected documents from an online tobacco industry document archive and analyzed them with an interpretive approach.

Results. Tobacco companies conceptualized credibility not as being worthy of belief or confidence but as inspiring it. Thus, credibility was understood primarily as altering public perception of the industry. ‘‘Truth’’ was largely absent from tobacco industry conceptualizations of credibility, which were linked with ‘‘responsibility’’ and ‘‘reasonableness.’’ However, industry research found that the public regarded credibility and responsibility differently, expecting these to entail truth telling, advertising reductions, less harmful products, apologies for deception, making amends, or exiting the tobacco business altogether. Overall, industry credibility-building projects failed repeatedly.

Conclusions. Public health discourse increasingly attends to the roles of corporations in promoting disease. Industries such as tobacco and alcohol have been identified as profiting from harmful products. Yet corporations’ ability to continue business as usual requires sustaining an implicit societal assent to their activities that depends on corporate credibility. For public health to address corporate disease promotion effectively, undermining corporate credibility may be strategically important.

Key Words: Public Health Practice, Tobacco Control, Tobacco







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the American Public Health Association